BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23225488)

  • 1. Refractory trigeminal neuralgia. Non-surgical treatment options.
    Cruccu G; Truini A
    CNS Drugs; 2013 Feb; 27(2):91-6. PubMed ID: 23225488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAN-EFNS guidelines on trigeminal neuralgia management.
    Cruccu G; Gronseth G; Alksne J; Argoff C; Brainin M; Burchiel K; Nurmikko T; Zakrzewska JM; ;
    Eur J Neurol; 2008 Oct; 15(10):1013-28. PubMed ID: 18721143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain.
    Di Stefano G; La Cesa S; Truini A; Cruccu G
    J Headache Pain; 2014 Jun; 15(1):34. PubMed ID: 24912658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options.
    Al-Quliti KW
    Neurosciences (Riyadh); 2015 Apr; 20(2):107-14. PubMed ID: 25864062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Academy of Neurology guideline on trigeminal neuralgia.
    Bendtsen L; Zakrzewska JM; Abbott J; Braschinsky M; Di Stefano G; Donnet A; Eide PK; Leal PRL; Maarbjerg S; May A; Nurmikko T; Obermann M; Jensen TS; Cruccu G
    Eur J Neurol; 2019 Jun; 26(6):831-849. PubMed ID: 30860637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of trigeminal neuralgia].
    Bakker NA; van Dijk JM; Wagemakers M; van der Weide HL; Beese U; Metzemaekers JD
    Ned Tijdschr Geneeskd; 2014; 158():A7468. PubMed ID: 24893812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    Pain; 2002 Feb; 95(3):259-266. PubMed ID: 11839425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial.
    Burmeister J; Holle D; Bock E; Ose C; Diener HC; Obermann M
    Trials; 2015 Dec; 16():550. PubMed ID: 26634453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies.
    Gronseth G; Cruccu G; Alksne J; Argoff C; Brainin M; Burchiel K; Nurmikko T; Zakrzewska JM
    Neurology; 2008 Oct; 71(15):1183-90. PubMed ID: 18716236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trigeminal neuralgia: a practical guide.
    Lambru G; Zakrzewska J; Matharu M
    Pract Neurol; 2021 Oct; 21(5):392-402. PubMed ID: 34108244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia.
    Zakrzewska JM; Patsalos PN
    J Neurol Neurosurg Psychiatry; 1989 Apr; 52(4):472-6. PubMed ID: 2738589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia.
    Gomez-Arguelles JM; Dorado R; Sepulveda JM; Herrera A; Arrojo FG; Aragón E; Huete CR; Terrón C; Anciones B
    J Clin Neurosci; 2008 May; 15(5):516-9. PubMed ID: 18378142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up.
    Xiromerisiou G; Lampropoulos IC; Dermitzakis EV; Vikelis M; Marogianni C; Mysiris D; Argyriou AA
    Toxins (Basel); 2023 Aug; 15(9):. PubMed ID: 37755965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromodulators for Atypical Facial Pain and Neuralgias: A Systematic Review and Meta-Analysis.
    Do TM; Unis GD; Kattar N; Ananth A; McCoul ED
    Laryngoscope; 2021 Jun; 131(6):1235-1253. PubMed ID: 33037835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review.
    Naderi Y; Rad M; Sadatmoosavi A; Khaleghi E; Khorrami Z; Chamani G; Shabani M
    Clin Exp Dent Res; 2024 Apr; 10(2):e882. PubMed ID: 38558383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia: a meta-analysis.
    Wang QP; Bai M
    CNS Drugs; 2011 Oct; 25(10):847-57. PubMed ID: 21936587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.
    Grant SM; Faulds D
    Drugs; 1992 Jun; 43(6):873-88. PubMed ID: 1379159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine for neuropathic pain.
    Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007963. PubMed ID: 29199767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A as an alternative way to treat trigeminal neuralgia: a systematic review.
    Ostrowski H; Roszak J; Komisarek O
    Neurol Neurochir Pol; 2019; 53(5):327-334. PubMed ID: 31397877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trigeminal neuralgia : Modern diagnostic workup and treatment].
    Ruscheweyh R; Lutz J; Mehrkens JH
    Schmerz; 2020 Dec; 34(6):486-494. PubMed ID: 32960312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.